NAYA Biosciences announces strategic decision to separate fertility and oncology
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 15 2025
0mins
Company Name Change and Focus: INVO Fertility, formerly NAYA Biosciences, will separate its fertility and oncology operations, returning to a focus on the fertility marketplace, including new clinic operations and distribution of the INVOcell device.
Ticker Symbol Update: The company will be renamed "INVO Fertility, Inc." effective April 14, 2025, with a new Nasdaq ticker symbol "IVF" to be implemented shortly thereafter.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
